Paper on the Neutrocheck® solution published in Trends in Biotechnology

Advancements in AI and multiplexed sensors drive personalized healthcare, integrating diagnostics, treatment, and monitoring. Integrated health connects stakeholders, devices, and services via digital platforms for accessible, patient-centric care. Crucial to personalized medicine, multiplexed point-of-care tests link results to digital systems. Lateral flow tests, revitalized by SARS-CoV-2, exemplify this technology. Neutrocheck® embodies these trends, offering an affordable, digitally-linked diagnostic platform for comprehensive, personalized cancer care. This convergence underscores technology's potential to transform healthcare, fostering inclusive and connected approaches to patient well-being.

Read the full paper here